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Sarah Azari, Michael Su, Benjamin Croll, MD, Joseph Feliciano, MD and Angelo Baccala, MD
Lehigh Valley Health Network, Allentown, Pa.
Introduction
•  Cell Cycle Progression (CCP) score, or the Prolaris score, 
has been shown to independently predict cancer related 
death, biochemical recurrence, and metastases in patients 
with prostate cancer1,2
•  The association between CCP score and adverse pathology 
after radical prostatectomy has not yet been evaluated
Methods
•  Patients who had received CCP testing and undergone 
radical prostatectomy between 2015 and 2018 were 
assessed for adverse pathology
•		Adverse	pathology	was	defined	as	any	of	the	following:
   post-operative Gleason score of 8 or greater
   positive lymph nodes
   extracapsular extension (stage pT3a) or seminal vesicle 
invasion (stage pT3b) 




•  Logistic regression was performed using SPSS to  
ascertain the relationship between CCP score with  
adverse pathology and positive margins. 
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Conclusions
•  CCP scores are positively correlated with 
adverse pathology after radical prostatectomy
•  CCP may be a useful tool to predict adverse 
pathology
•  This information may help men with low risk 
prostate cancer make a more educated 
decision regarding active surveillance versus 
immediate therapy
•  Further analysis adjusting for patient risk 
should	be	done	to	confirm	these	results.	
Results
•  173 patients met inclusion criteria, of which 53 demonstrated adverse pathology 
•  Patients from most American Urologic Association risk categories were represented, with the 
majority being intermediate risk (Table 1)
•  The number of patients with lymph node involvement, Gleason stage of 8 or higher, extracapsular 
extension, and seminal vesicle invasion is shown in Table 2
•  Based on binary logistic regression testing, CCP was positively associated with adverse pathology, 
with an odds ratio per 1 CCP units of 3.246 (p<0.001)
•		There	was	not	a	significant	relationship	between	CCP	score	and	positive	margins.	
Table 1: Breakdown of patients by American 




High/Very high 2 1.16%
Not found 1 0.58%
Table 2: Patients with adverse pathology
Positive lymph nodes 1 0.58%
Gleason stage of 8  
or greater 13 7.51%
Extracapsular extension 32 18.39%
Seminal vesicle invasion 14 8.05%
